Metabolomic and transcriptomic analysis reveals endogenous substrates and metabolic adaptation in rats lacking Abcg2 and Abcb1a transporters.

Abcg2/Bcrp and Abcb1a/Pgp are xenobiotic efflux transporters limiting substrate permeability in the gastrointestinal system and brain, and increasing renal and hepatic drug clearance. The systemic impact of Bcrp and Pgp ablation on metabolic homeostasis of endogenous substrates is incompletely under...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Samit Ganguly, David Finkelstein, Timothy I Shaw, Ryan D Michalek, Kimberly M Zorn, Sean Ekins, Kazuto Yasuda, Yu Fukuda, John D Schuetz, Kamalika Mukherjee, Erin G Schuetz
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/b18f9e558107487fa2603259aa77bcbd
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b18f9e558107487fa2603259aa77bcbd
record_format dspace
spelling oai:doaj.org-article:b18f9e558107487fa2603259aa77bcbd2021-12-02T20:15:23ZMetabolomic and transcriptomic analysis reveals endogenous substrates and metabolic adaptation in rats lacking Abcg2 and Abcb1a transporters.1932-620310.1371/journal.pone.0253852https://doaj.org/article/b18f9e558107487fa2603259aa77bcbd2021-01-01T00:00:00Zhttps://doi.org/10.1371/journal.pone.0253852https://doaj.org/toc/1932-6203Abcg2/Bcrp and Abcb1a/Pgp are xenobiotic efflux transporters limiting substrate permeability in the gastrointestinal system and brain, and increasing renal and hepatic drug clearance. The systemic impact of Bcrp and Pgp ablation on metabolic homeostasis of endogenous substrates is incompletely understood. We performed untargeted metabolomics of cerebrospinal fluid (CSF) and plasma, transcriptomics of brain, liver and kidney from male Sprague Dawley rats (WT) and Bcrp/Pgp double knock-out (dKO) rats, and integrated metabolomic/transcriptomic analysis to identify putative substrates and perturbations in canonical metabolic pathways. A predictive Bayesian machine learning model was used to predict in silico those metabolites with greater substrate-like features for either transporters. The CSF and plasma levels of 169 metabolites, nutrients, signaling molecules, antioxidants and lipids were significantly altered in dKO rats, compared to WT rats. These metabolite changes suggested alterations in histidine, branched chain amino acid, purine and pyrimidine metabolism in the dKO rats. Levels of methylated and sulfated metabolites and some primary bile acids were increased in dKO CSF or plasma. Elevated uric acid levels appeared to be a primary driver of changes in purine and pyrimidine biosynthesis. Alterations in Bcrp/Pgp dKO CSF levels of antioxidants, precursors of neurotransmitters, and uric acid suggests the transporters may contribute to the regulation of a healthy central nervous system in rats. Microbiome-generated metabolites were found to be elevated in dKO rat plasma and CSF. The altered dKO metabolome appeared to cause compensatory transcriptional change in urate biosynthesis and response to lipopolysaccharide in brain, oxidation-reduction processes and response to oxidative stress and porphyrin biosynthesis in kidney, and circadian rhythm genes in liver. These findings present insight into endogenous functions of Bcrp and Pgp, the impact that transporter substrates, inhibitors or polymorphisms may have on metabolism, how transporter inhibition could rewire drug sensitivity indirectly through metabolic changes, and identify functional Bcrp biomarkers.Samit GangulyDavid FinkelsteinTimothy I ShawRyan D MichalekKimberly M ZornSean EkinsKazuto YasudaYu FukudaJohn D SchuetzKamalika MukherjeeErin G SchuetzPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 16, Iss 7, p e0253852 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Samit Ganguly
David Finkelstein
Timothy I Shaw
Ryan D Michalek
Kimberly M Zorn
Sean Ekins
Kazuto Yasuda
Yu Fukuda
John D Schuetz
Kamalika Mukherjee
Erin G Schuetz
Metabolomic and transcriptomic analysis reveals endogenous substrates and metabolic adaptation in rats lacking Abcg2 and Abcb1a transporters.
description Abcg2/Bcrp and Abcb1a/Pgp are xenobiotic efflux transporters limiting substrate permeability in the gastrointestinal system and brain, and increasing renal and hepatic drug clearance. The systemic impact of Bcrp and Pgp ablation on metabolic homeostasis of endogenous substrates is incompletely understood. We performed untargeted metabolomics of cerebrospinal fluid (CSF) and plasma, transcriptomics of brain, liver and kidney from male Sprague Dawley rats (WT) and Bcrp/Pgp double knock-out (dKO) rats, and integrated metabolomic/transcriptomic analysis to identify putative substrates and perturbations in canonical metabolic pathways. A predictive Bayesian machine learning model was used to predict in silico those metabolites with greater substrate-like features for either transporters. The CSF and plasma levels of 169 metabolites, nutrients, signaling molecules, antioxidants and lipids were significantly altered in dKO rats, compared to WT rats. These metabolite changes suggested alterations in histidine, branched chain amino acid, purine and pyrimidine metabolism in the dKO rats. Levels of methylated and sulfated metabolites and some primary bile acids were increased in dKO CSF or plasma. Elevated uric acid levels appeared to be a primary driver of changes in purine and pyrimidine biosynthesis. Alterations in Bcrp/Pgp dKO CSF levels of antioxidants, precursors of neurotransmitters, and uric acid suggests the transporters may contribute to the regulation of a healthy central nervous system in rats. Microbiome-generated metabolites were found to be elevated in dKO rat plasma and CSF. The altered dKO metabolome appeared to cause compensatory transcriptional change in urate biosynthesis and response to lipopolysaccharide in brain, oxidation-reduction processes and response to oxidative stress and porphyrin biosynthesis in kidney, and circadian rhythm genes in liver. These findings present insight into endogenous functions of Bcrp and Pgp, the impact that transporter substrates, inhibitors or polymorphisms may have on metabolism, how transporter inhibition could rewire drug sensitivity indirectly through metabolic changes, and identify functional Bcrp biomarkers.
format article
author Samit Ganguly
David Finkelstein
Timothy I Shaw
Ryan D Michalek
Kimberly M Zorn
Sean Ekins
Kazuto Yasuda
Yu Fukuda
John D Schuetz
Kamalika Mukherjee
Erin G Schuetz
author_facet Samit Ganguly
David Finkelstein
Timothy I Shaw
Ryan D Michalek
Kimberly M Zorn
Sean Ekins
Kazuto Yasuda
Yu Fukuda
John D Schuetz
Kamalika Mukherjee
Erin G Schuetz
author_sort Samit Ganguly
title Metabolomic and transcriptomic analysis reveals endogenous substrates and metabolic adaptation in rats lacking Abcg2 and Abcb1a transporters.
title_short Metabolomic and transcriptomic analysis reveals endogenous substrates and metabolic adaptation in rats lacking Abcg2 and Abcb1a transporters.
title_full Metabolomic and transcriptomic analysis reveals endogenous substrates and metabolic adaptation in rats lacking Abcg2 and Abcb1a transporters.
title_fullStr Metabolomic and transcriptomic analysis reveals endogenous substrates and metabolic adaptation in rats lacking Abcg2 and Abcb1a transporters.
title_full_unstemmed Metabolomic and transcriptomic analysis reveals endogenous substrates and metabolic adaptation in rats lacking Abcg2 and Abcb1a transporters.
title_sort metabolomic and transcriptomic analysis reveals endogenous substrates and metabolic adaptation in rats lacking abcg2 and abcb1a transporters.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/b18f9e558107487fa2603259aa77bcbd
work_keys_str_mv AT samitganguly metabolomicandtranscriptomicanalysisrevealsendogenoussubstratesandmetabolicadaptationinratslackingabcg2andabcb1atransporters
AT davidfinkelstein metabolomicandtranscriptomicanalysisrevealsendogenoussubstratesandmetabolicadaptationinratslackingabcg2andabcb1atransporters
AT timothyishaw metabolomicandtranscriptomicanalysisrevealsendogenoussubstratesandmetabolicadaptationinratslackingabcg2andabcb1atransporters
AT ryandmichalek metabolomicandtranscriptomicanalysisrevealsendogenoussubstratesandmetabolicadaptationinratslackingabcg2andabcb1atransporters
AT kimberlymzorn metabolomicandtranscriptomicanalysisrevealsendogenoussubstratesandmetabolicadaptationinratslackingabcg2andabcb1atransporters
AT seanekins metabolomicandtranscriptomicanalysisrevealsendogenoussubstratesandmetabolicadaptationinratslackingabcg2andabcb1atransporters
AT kazutoyasuda metabolomicandtranscriptomicanalysisrevealsendogenoussubstratesandmetabolicadaptationinratslackingabcg2andabcb1atransporters
AT yufukuda metabolomicandtranscriptomicanalysisrevealsendogenoussubstratesandmetabolicadaptationinratslackingabcg2andabcb1atransporters
AT johndschuetz metabolomicandtranscriptomicanalysisrevealsendogenoussubstratesandmetabolicadaptationinratslackingabcg2andabcb1atransporters
AT kamalikamukherjee metabolomicandtranscriptomicanalysisrevealsendogenoussubstratesandmetabolicadaptationinratslackingabcg2andabcb1atransporters
AT eringschuetz metabolomicandtranscriptomicanalysisrevealsendogenoussubstratesandmetabolicadaptationinratslackingabcg2andabcb1atransporters
_version_ 1718374603701616640